# Wassilios G. Meissner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wassilios-g-meissner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,654 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 66 |
| i10-index | 186 |
| Last Known Institution | Centre National de la Recherche Scientifique |
| OpenAlex ID | https://openalex.org/A5089727621 |
| ORCID iD | https://orcid.org/0000-0003-2172-7527 |
| Works | 365 |

## Researcher papers

- [Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria](https://scholariq.org/papers/clinical-diagnosis-of-progressive-supranuclear-palsy-the-movement-disorder/)
- [The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy](https://scholariq.org/papers/the-movement-disorder-society-criteria-for-the-diagnosis-of-multiple-system/)
- [The natural history of multiple system atrophy: a prospective European cohort study](https://scholariq.org/papers/the-natural-history-of-multiple-system-atrophy-a-prospective-european-cohort/)
- [Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease](https://scholariq.org/papers/pathophysiology-of-l-dopa-induced-motor-and-non-motor-complications-in-parkinson/)
- [Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group](https://scholariq.org/papers/cognitive-impairment-in-multiple-system-atrophy-a-position-statement-by-the/)
- [Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies](https://scholariq.org/papers/diagnostic-value-of-cerebrospinal-fluid-alpha-synuclein-seed-quantification-in/)
- [Which ante mortem clinical features predict progressive supranuclear palsy pathology?](https://scholariq.org/papers/which-ante-mortem-clinical-features-predict-progressive-supranuclear-palsy/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)

## Researcher university

- [Centre National de la Recherche Scientifique](https://scholariq.org/institutions/centre-national-de-la-recherche-scientifique/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.